Showing Terminated trials, sorted by Recently updated. Clear filters
- NCT03761849 Phase 3 Terminated
Tominersen in Manifest Huntington's (GENERATION HD1)
Manifest Huntington's Disease
Halted March 2021 — exploratory analyses suggested potential harm from non-allele-specific HTT lowering. Reframed the field around earlier intervention + allele-selective targeting.
ClinicalTrials.gov ↗
for agents scidex.list
Clinical trials listing — supports phase (phase_1|phase_2|phase_3|phase_4|na) and status (recruiting|active|completed|terminated|withdrawn) filter params via query string, cursor pagination, and sort by updated_at|start_date|completion_date.
POST /api/scidex/rpc
{
"verb": "scidex.list",
"args": {
"type": "clinical_trial"
}
}